INM Stock Overview
Focuses on the development of medical simulators based on Virtual Realty technology for use in education in esthetic and clinical dermatology. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
InventionMed S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł0.19 |
| 52 Week High | zł0.26 |
| 52 Week Low | zł0.15 |
| Beta | 0.45 |
| 1 Month Change | -8.47% |
| 3 Month Change | 20.38% |
| 1 Year Change | -18.88% |
| 3 Year Change | 17.94% |
| 5 Year Change | -58.46% |
| Change since IPO | -87.40% |
Recent News & Updates
Recent updates
Shareholder Returns
| INM | PL Medical Equipment | PL Market | |
|---|---|---|---|
| 7D | -1.7% | 2.3% | 1.5% |
| 1Y | -18.9% | -15.8% | 4.7% |
Return vs Industry: INM underperformed the Polish Medical Equipment industry which returned -16.8% over the past year.
Return vs Market: INM underperformed the Polish Market which returned 5.4% over the past year.
Price Volatility
| INM volatility | |
|---|---|
| INM Average Weekly Movement | 9.8% |
| Medical Equipment Industry Average Movement | 5.8% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in PL Market | 10.4% |
| 10% least volatile stocks in PL Market | 3.4% |
Stable Share Price: INM's share price has been volatile over the past 3 months compared to the Polish market.
Volatility Over Time: INM's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Polish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 4 | Tomasz Kierul | inventionmed.com |
InventionMed S.A. focuses on the development of medical simulators based on Virtual Realty technology for use in education in esthetic and clinical dermatology. Its flagship project is TutorDerm, a simulator and an application that lets users perform actions necessary to treat specific dermatological diseases. The company also offers double immersion, and Virtual Syringe, a training equipment for specialists in clinical and aesthetic dermatology.
InventionMed S.A. Fundamentals Summary
| INM fundamental statistics | |
|---|---|
| Market cap | zł38.33m |
| Earnings (TTM) | -zł4.00m |
| Revenue (TTM) | zł277.76k |
138.0x
P/S Ratio-9.6x
P/E RatioIs INM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| INM income statement (TTM) | |
|---|---|
| Revenue | zł277.76k |
| Cost of Revenue | zł180.18k |
| Gross Profit | zł97.58k |
| Other Expenses | zł4.10m |
| Earnings | -zł4.00m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.02 |
| Gross Margin | 35.13% |
| Net Profit Margin | -1,441.23% |
| Debt/Equity Ratio | 0% |
How did INM perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/21 08:43 |
| End of Day Share Price | 2025/02/21 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
InventionMed S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.